betahistine and Benign Paroxysmal Positional Vertigo

betahistine has been researched along with Benign Paroxysmal Positional Vertigo in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (53.33)24.3611
2020's7 (46.67)2.80

Authors

AuthorsStudies
Hui, J; Ji, Z; Lei, Q; Zi, D1
Ding, R; Li, W; Sun, J; Wang, H; Xu, J; Zhang, Y; Zhao, Z1
Erdur, ZB; Evran, N1
Gerami, H; Jalali, MM; Razaghi, S; Saberi, A1
Li, HW; Liu, JP; Wang, WQ; Wu, PX1
Amelin, AV; Guseva, AL; Kunelskaya, NL; Lilenko, SV; Lyapin, AV; Melnikov, OA; Samartcev, IN; Voronov, VA; Zamergrad, MV; Zaytseva, OV1
Kaur, J; Shamanna, K1
Buitrago, D; Castro-Moreno, C; Sanchez-Vanegas, G1
Cao, W; Hu, Y; Li, H; Wu, P1
Almeda Ortega, J; Arias Agudelo, OL; Azagra Ledesma, R; Ballve Moreno, JL; Bigas Aguilera, O; Buitrago Olaya, CJ; Capella Guillén, A; Carrillo Muñoz, R; Hernández Sánchez, AM; Martin Cantera, C; Monteverde Curto, X; Moreno Farres, N; Rando Matos, Y; Rodero Perez, E; Rubio Ripollès, C; Sepulveda Palacios, PC; Vasudeva, A; Villar Balboa, I1
Acar, B; Buran, Y; Karasen, RM1
Hussain, K; Murdin, L; Schilder, AG1
Pommer, P1
Guneri, EA; Kustutan, O1
Balaban, B; Maslovara, S; Penavic, IP; Puksec, M; Soldo, SB1

Reviews

3 review(s) available for betahistine and Benign Paroxysmal Positional Vertigo

ArticleYear
Efficacy of Epley's maneuver plus betahistine in the management of PC-BPPV: A systematic review and meta-analysis.
    Medicine, 2023, Mar-31, Volume: 102, Issue:13

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Humans; Randomized Controlled Trials as Topic; Treatment Outcome

2023
[Betahistine in vestibular disorders: current concepts and perspectives].
    Vestnik otorinolaringologii, 2021, Volume: 86, Issue:2

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; Meniere Disease; Vestibular Diseases

2021
Betahistine for symptoms of vertigo.
    The Cochrane database of systematic reviews, 2016, Jun-21, Issue:6

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Humans; Randomized Controlled Trials as Topic; Vertigo

2016

Trials

7 trial(s) available for betahistine and Benign Paroxysmal Positional Vertigo

ArticleYear
[Intervention strategies for residual dizziness after successful repositioning maneuvers in benign paroxysmal positional vertigo: a single center randomized controlled trial].
    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2021, Jan-07, Volume: 56, Issue:1

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; Patient Positioning; Vestibule, Labyrinth

2021
Management of Benign Paroxysmal Positional Vertigo: A Comparative Study between Epleys Manouvre and Betahistine.
    The international tinnitus journal, 2017, Jun-01, Volume: 21, Issue:1

    Topics: Administration, Oral; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Combined Modality Therapy; Humans; Middle Aged; Otolaryngology; Outpatients; Vasodilator Agents

2017
Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial.
    BMJ open, 2019, 06-18, Volume: 9, Issue:6

    Topics: Adult; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Female; Humans; Male; Middle Aged; Patient Positioning; Physical Therapy Modalities; Practice Guidelines as Topic; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents; Vestibule, Labyrinth

2019
Effectiveness of the Epley's maneuver performed in primary care to treat posterior canal benign paroxysmal positional vertigo: study protocol for a randomized controlled trial.
    Trials, 2014, May-21, Volume: 15

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Clinical Protocols; General Practitioners; Histamine Agonists; Humans; Physical Therapy Modalities; Primary Health Care; Research Design; Spain; Time Factors; Treatment Outcome; Urban Health Services

2014
Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV).
    B-ENT, 2015, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benign Paroxysmal Positional Vertigo; Betahistine; Child; Combined Modality Therapy; Dizziness; Female; Ginkgo biloba; Humans; Male; Middle Aged; Patient Positioning; Phytotherapy; Plant Extracts; Treatment Outcome; Trimetazidine; Vasodilator Agents; Young Adult

2015
The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012, Volume: 146, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Physical Therapy Modalities; Posture; Semicircular Canals; Treatment Outcome; Vasodilator Agents; Vertigo; Young Adult

2012
Benign paroxysmal positional vertigo (BPPV): influence of pharmacotherapy and rehabilitation therapy on patients' recovery rate and life quality.
    NeuroRehabilitation, 2012, Volume: 31, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Benign Paroxysmal Positional Vertigo; Betahistine; Female; Histamine Agonists; Humans; Male; Middle Aged; Neurologic Examination; Patient Positioning; Patient Satisfaction; Quality of Life; Recovery of Function; Surveys and Questionnaires; Treatment Outcome; Vertigo

2012

Other Studies

5 other study(ies) available for betahistine and Benign Paroxysmal Positional Vertigo

ArticleYear
Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway.
    Biological research, 2022, Apr-04, Volume: 55, Issue:1

    Topics: Animals; Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; MAP Kinase Signaling System; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt

2022
Effect of betahistine treatment on dizziness and anxiety symptoms of BPPV patients.
    Nigerian journal of clinical practice, 2023, Volume: 26, Issue:9

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Dizziness; Humans; Quality of Life; Treatment Outcome

2023
The Impact of Betahistine versus Dimenhydrinate in the Resolution of Residual Dizziness in Patients with Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial.
    The Annals of otology, rhinology, and laryngology, 2020, Volume: 129, Issue:5

    Topics: Adolescent; Adult; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Dimenhydrinate; Dizziness; Double-Blind Method; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vasodilator Agents; Young Adult

2020
Betahistine in the Treatment of Peripheral Vestibular Vertigo: Results of a Real-Life Study in Primary Care.
    Ear, nose, & throat journal, 2020, Volume: 99, Issue:6

    Topics: Adult; Aged; Benign Paroxysmal Positional Vertigo; Betahistine; Colombia; Female; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Treatment Outcome; Vertigo

2020
    Deutsche medizinische Wochenschrift (1946), 2016, Volume: 141, Issue:22

    Topics: Benign Paroxysmal Positional Vertigo; Betahistine; Humans; Prevalence; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents; Vertigo

2016